Pharmaceutical Formulation and Processing Training

Currently there are no upcoming Pharmaceutical Formulation and Processing Training courses scheduled. Contact us to find out when the next course will run or if you need customized training. We can deliver this course and a broad range of other training topics at your location, off-site or virtually.

Contact us

About This Course

Pharmaceutical Formulation and Processing – Part 1

This intensive, interactive pharmaceutical formulation and processing training course allows aspiring Qualified Persons and other pharmaceutical professionals to understand the key quality requirements of non-sterile dosage forms such as tablets, capsules, liquids, topical medicines and inhalation products.

Pharmaceutical Formulation and Processing – Part 2

This intensive, interactive pharmaceutical training course provides aspiring QPs and other pharmaceutical professionals with the knowledge they need to understand the key quality requirements of parenteral products.

We teach you the important formulation requirements for each of these product types and how those requirements influence the performance of the medicine in the body. We also teach you the key processing steps in the production of these dosage forms, as well as critical quality attributes and critical process parameters. We also cover what can go wrong during the processing of medicinal products and the potential consequences to the safety, quality and efficacy of the medicine.

Once a new chemical entity has proved its potential in clinical studies, the challenge becomes formulating the compound into an effective medicine and manufacturing that medicine reliably so that safety, quality and efficacy are assured.

This course addresses two important activities of pharmaceutical formulation and processing, and provides key information on:

  • How the physico-chemical attributes of the drug and the therapeutic indication influence:
    • Route of administration
    • Dosage form
  • Assuring bioavailability
  • Methods of manufacture of the major dosage forms
  • Factors affecting suitability for use of the major dosage forms

The QP and pharmaceutical professionals must have a detailed understanding of these topics if they are to:

  • Assist in the design and implementation of relevant and effective quality systems for dosage form manufacture
  • Contribute to the risk assessment process for processing changes and unplanned deviations
  • Assess the adequacy of cleaning strategies and validation activities
  • Assess the potential impact of changes to physical and chemical attributes of starting materials

This course is approved by the Royal Society of Chemistry as suitable for its members’ continuing professional development.

Key Learning Objectives

On completion of this course delegates will know and understand:

  • The principles of drug design and formulation and the impact of even minor modifications on bioavailability/bioequivalence
  • The various processes involved in the manufacture of major dosage forms, e.g. tablets, capsules, oral liquids, topical liquids, creams and ointments, sterile products and inhalation products
  • The Good Manufacturing Practice (GMP) issues and challenges for the QP to enable informed release decisions
  • How to apply the knowledge to:
    • Risk management
    • Risk assessment
    • Problem solving and decision making
    • Auditing
  • The principles of technology transfer and process validation

Course Outline

Part 1

  • Pre-formulation issues and product development
  • Routes of administration
  • Non-sterile dosage forms: Tablets, capsules, inhalation products, liquids, creams and ointments:
    • Major processing methods
    • Formulation challenges for each route of administration
    • Critical process steps
    • Key GMP requirements
    • What goes wrong and the role of the QP
  • Principles of technology transfer
  • Principles of process validation and control

Part 2

Parenteral Products

  • Design, qualification and operation of cleanrooms
  • Pharmaceutical water systems
  • Methods of sterilization and aseptic processing
  • Formulation considerations
  • Major processing methods
  • Critical process steps
  • Risk-based decision-making and the role of the QP
  • Key GMP requirements, Annex 1 and the contamination control strategy

Who Should Attend

The Aspiring Qualified Person

  • Our pharmaceutical formulation and processing training course is generally considered as the best available and our QPs are held in high regard in the industry.
  • As well as being accepted in the UK, our training courses are well known and accepted by several EU countries including Ireland, the Netherlands, Austria, Hungary and Malta.
  • You are more likely to become a QP with us than with any other training provider.
  • Pragmatic training by experienced consultants supported by key academic staff from the University of Strathclyde, one of the UK’s top schools of pharmacy.

The Pharmaceutical Technical Professional

  • Not all the people attending these courses intend to become QPs. Many use the training to develop as technical managers in other areas of pharmaceutical manufacture and control.
  • Many industry professionals from a range of disciplines attend the courses as part of their continuing professional development. Taken with some of our other QP modules, this course is designed to lead to postgraduate certificate, diploma and MSc qualifications.

Course Tutors

Each course tutor has a minimum of 25 years’ hands-on experience in the manufacture of every major dosage form. APIs, biologics, tablets, liquids, creams, ointments, sterile as well as non-sterile dosage forms – you name it, they have made it.

Course tutors will be selected from the following:

Part 1:

  • Catherine Kay
  • Samantha Clack
  • Tony Mayhall
  • Vicky Baulch
  • Bruce Davis
  • Richard Kettlewell
  • Luis Bimbo – University of Strathclyde

Part 2:

  • Erika Notman
  • Darren Jones
  • Lana Morrison
  • James Culyer
  • Emma Ewins

Discounts

Multi-delegate discounts available. Discounts also offered to NHS staff, regulators and charities.